Next Plant-Based Unicorn
The plant-based industry has been ignited. Pay close attention to this stock.
Learn more.
David J. Schlanger, insider at Progyny

David J. Schlanger Insider Information

CEO of Progyny

David Schlanger serves as CEO of Progyny Inc. 

Schlanger has been at the helm of Progyny since 2017, leading the fertility benefits management company in providing inclusive and comprehensive fertility care that benefits patients, employers and physicians. 

Prior to Progyny, Schlanger spent 15 years with WebMD. His most recent role at the medical internet company was as CEO from 2013 to 2016, after serving as interim CEO from May to August 2013. During his tenure at WebMD, Schlanger led over 1,700 employees to grow revenue from $470 million to over $700 million. 

Other roles he held at the company included senior vice president of strategic and corporate development and senior vice president of corporate development, the latter of which he held for 10 years. 

Schlanger’s early career included a five-year stint as an associate with Latham & Watkins, where he was a senior transactions attorney. From 1990 to 1993, he worked as the vice president of acquisitions for Medco Containment Services before joining Merck as their executive director of business development from 1993 to 1994. Directly prior to his time at WebMD, Schlanger spent six years as the senior vice president for corporate development at Medical Manager Corp. 

Schlanger holds a bachelor’s degree in economics from Georgetown University, and he earned his J.D. from the University of Michigan Law School.

What is David J. Schlanger's net worth?

The estimated net worth of David J. Schlanger is at least $2.79 million as of June 2nd, 2021. Mr. Schlanger owns 50,000 shares of Progyny stock worth more than $2,786,000 as of August 3rd. This net worth approximation does not reflect any other investments that Mr. Schlanger may own. Additionally, Mr. Schlanger receives an annual salary of $987,310.00 as CEO at Progyny.

How old is David J. Schlanger?

Mr. Schlanger is currently 62 years old. There are 3 older executives and no younger executives at Progyny.

What is David J. Schlanger's salary?

As the CEO of Progyny, Inc., Mr. Schlanger earned a total compensation package of $987,312.00 in 2020. Mr. Schlanger earned a salary of $500,000.00, a bonus of $125,000.00, non-equity compensation of $350,000.00, and other compensation of $12,312.00.

How do I contact David J. Schlanger?

The corporate mailing address for Mr. Schlanger and other Progyny executives is 1359 BROADWAY, NEW YORK NY, 10018. Progyny can also be reached via phone at 212-888-3124 and via email at [email protected]

Has David J. Schlanger been buying or selling shares of Progyny?

David J. Schlanger has not been actively trading shares of Progyny within the last three months. Most recently, David J. Schlanger sold 105,987 shares of the business's stock in a transaction on Thursday, June 24th. The shares were sold at an average price of $59.46, for a transaction totalling $6,301,987.02.

Who are Progyny's active insiders?

Progyny's insider roster includes Peter Anevski (COO), Norman Payson (Director), and David Schlanger (CEO).

Are insiders buying or selling shares of Progyny?

In the last twelve months, Progyny insiders bought shares 1 times. They purchased a total of 2,000 shares worth mmore than $14,060.00. In the last twelve months, insiders at the sold shares 146 times. They sold a total of 6,208,500 shares worth mmore than $277,248,262.42. The most recent insider tranaction occured on July, 23rd when Jennifer Bealer EVP bought 1,930 shares worth more than $108,852.00. Insiders at Progyny own 19.4 % of the company.

Information on this page was last updated on 7/23/2021.

David J. Schlanger Insider Trading History at Progyny

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/24/2021Sell105,987$59.46$6,301,987.02View SEC Filing Icon  
6/2/2021Sell50,000$63.70$3,185,000.0050,000View SEC Filing Icon  
5/5/2021Sell50,000$53.21$2,660,500.0050,000View SEC Filing Icon  
5/3/2021Sell50,000$55.79$2,789,500.0050,000View SEC Filing Icon  
4/8/2021Sell36,676$45.58$1,671,692.08300View SEC Filing Icon  
4/6/2021Sell112,020$46.10$5,164,122.00300View SEC Filing Icon  
4/1/2021Sell1,004$46.19$46,374.761,004View SEC Filing Icon  
3/12/2021Sell55,430$47.57$2,636,805.1013,003View SEC Filing Icon  
3/10/2021Sell13,003$47.50$617,642.5013,003View SEC Filing Icon  
2/3/2021Sell50,000$47.84$2,392,000.0050,000View SEC Filing Icon  
2/1/2021Sell50,000$47.92$2,396,000.0050,000View SEC Filing Icon  
1/6/2021Sell20,010$43.29$866,232.90View SEC Filing Icon  
1/4/2021Sell40,000$42.47$1,698,800.00View SEC Filing Icon  
12/3/2020Sell40,000$37.12$1,484,800.00View SEC Filing Icon  
12/1/2020Sell40,000$35.50$1,420,000.00View SEC Filing Icon  
11/11/2020Sell36,940$29.38$1,085,297.20View SEC Filing Icon  
11/9/2020Sell40,000$29.30$1,172,000.00View SEC Filing Icon  
11/5/2020Sell500$27.65$13,825.00View SEC Filing Icon  
10/5/2020Sell40,000$29.43$1,177,200.00View SEC Filing Icon  
10/1/2020Sell40,000$28.73$1,149,200.00View SEC Filing Icon  
9/28/2020Sell26,331$28.54$751,486.74View SEC Filing Icon  
9/25/2020Sell40,000$28.40$1,136,000.00View SEC Filing Icon  
8/10/2020Sell46,521$27.72$1,289,562.12592,489View SEC Filing Icon  
8/7/2020Sell1,000$27.49$27,490.00592,489View SEC Filing Icon  
8/4/2020Sell104$27.24$2,832.96600,010View SEC Filing Icon  
7/9/2020Sell20,000$25.94$518,800.00600,010View SEC Filing Icon  
7/7/2020Sell20,000$25.85$517,000.00600,010View SEC Filing Icon  
7/2/2020Sell40,000$25.99$1,039,600.00600,010View SEC Filing Icon  
6/8/2020Sell20,000$25.07$501,400.00591,794View SEC Filing Icon  
6/5/2020Sell58,075$24.93$1,447,809.75591,794View SEC Filing Icon  
6/3/2020Sell6,741$24.74$166,772.34600,010View SEC Filing Icon  
6/1/2020Sell20,000$24.82$496,400.00600,010View SEC Filing Icon  
5/15/2020Sell20,000$24.81$496,200.00631,498View SEC Filing Icon  
5/13/2020Sell51,488$25.14$1,294,408.32631,498View SEC Filing Icon  
5/11/2020Sell8,512$22.17$188,711.04600,010View SEC Filing Icon  
5/8/2020Sell20,000$22.73$454,600.00600,010View SEC Filing Icon  
10/29/2019Sell960,007$16.39$15,734,514.73
See Full Table

David J. Schlanger Buying and Selling Activity at Progyny

This chart shows David J Schlanger's buying and selling at Progyny by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Progyny Company Overview

Progyny logo
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
Read More

Today's Range

Now: $55.72
Low: $54.50
High: $56.43

50 Day Range

MA: $60.04
Low: $53.36
High: $64.95

2 Week Range

Now: $55.72
Low: $23.56
High: $66.61

Volume

401,570 shs

Average Volume

936,349 shs

Market Capitalization

$4.93 billion

P/E Ratio

97.76

Dividend Yield

N/A

Beta

1.79
Next Plant-Based Unicorn
The plant-based industry has been ignited. Pay close attention to this stock.
Learn more.